Our previous recombination and biochemical analyses have led to the hypothesis that the tumor suppressor p53 monitors homologous recombination, a function which was previously attributed to the mismatch repair protein MSH2. Here, we show that a certain fraction of p53 is concentrated within discrete nuclear foci of cells synchronized in G1 phase, a pattern which becomes even more pronounced in S phase, especially after g-ray treatment. p53 foci show some colocalization with MSH2 within distinct foci during G1 phase, while dots formed by BRCA1 display an independent localization pattern. In S phase nuclei, p53 foci almost completely colocalize with MSH2 foci and associate with the recombination surveillance factor BRCA1 in irradiated S phase cells. These p53 and MSH2 foci also show significant overlaps with foci of the recombination enzymes Rad50 and Rad51, which for the first time unveiled recombination-related functions of p53 in replicating cells. During S phase, p53 and MSH2 are maximally active in binding to early recombination intermediates, and coexist within the same nuclear DNA-protein complexes. Our data suggest that p53 is linked similarly to homologous recombination as MSH2 and provide further evidence for the new concept of a dual role of p53 in the regulation of growth and repair.
Introduction
MSH2 is a tumor suppressor linked to hereditary nonpolyposis colorectal cancer (HNPCC), alterations in the p53 gene are the most frequent mutations found in a variety of different tumors (Hollstein et al., 1994; Modrich and Lahue, 1996) . Consistently, deficits in either MSH2 or p53 cause the accelerated formation of tumors in the corresponding knockout mice (Donehower et al., 1992; De Wind et al., 1995; Reitmair et al., 1995) . Synergistically increased cancer susceptibilities of the double knockouts indicate complementary anticarcinogenic activities for these multi-functional proteins (Cranston et al., 1997) . In MSH27/7 mice genomic instabilities are associated with mismatch repair deficiencies and a hyperrecombinative phenotype (De Wind et al., 1995) . Genomic instabilities in p537/7 mice are characterized by a high degree of aneuploidies, gene amplification rates, and sister chromatid exchanges (Livingstone et al., 1992; Ishizaki et al., 1994) .
A central role in maintaining the genome integrity was attributed to p53, when it was understood that p53 halts the cell cycle or induces apoptosis in response to various stress signals (Lane, 1992; Levine, 1997) . Transcriptional transactivation of target genes is required for the p53-mediated arrest in G1, in G2, as well as for many of the apoptotic responses. Most of the cancer-related p53-mutants show defects in checkpoint control. Therefore, until recently, p53 was believed to exclusively avoid the manifestation of DNA damage by transcriptionally signaling cell cycle arrest or apoptosis. However, further mechanisms might contribute to the genome stabilizing and tumor suppressor functions of p53, as indicated by the absence of tumor formation after treatment of mice with g-ray and a compound, which inactivates transcriptional and apoptotic functions of p53 (Komarov et al., 1999) . A direct participation of p53 in DNA repair processes is conceivable due to biochemical activities of p53 in DNA damage recognition, reannealing, exonucleolytic degradation, and due to interactions with replication and repair factors, such as the human strand transferase hRad51 and the breast cancer gene product BRCA1 (Albrechtsen et al., 1999) . More specifically, an involvement of p53 in recombinative repair processes was indicated, because spontaneous homologous recombination (HR) processes were deregulated in cells, in which p53 was inactivated by genetic alterations or by viral protein interactions (Wiesmu¨ller et al., 1996; Bertrand et al., 1997; Mekeel et al., 1997) . The identification of cancer-related separation of function mutations made it unlikely that the regulation of HR is merely an indirect effect of p53's activities in transcription and growth control, and suggested that functions in recombinative repair contribute to tumor suppression Dudenho¨ffer et al., 1999; Willers et al., 2000) . Mechanistic studies indicated that p53 regulates HR events involving Rad51-dependent strand invasion rather than single-strand annealing processes (SSA) and unveiled an effect of certain mismatched bases within the heteroduplex generated by strand exchange (Dudenho¨ffer et al., 1998; Saintigny et al., 1999; Su¨sse et al., 2000) . This has led to the hypothesis that p53 monitors the fidelity of HR processes to avoid errorprone repair.
So far, fidelity control of recombination has been ascribed to MSH2 and to its bacterial homologue MutS, because these proteins inhibit DNA exchange processes between divergent sequences beyond their roles in sensing base mispairings during postreplicative mismatch repair (Modrich and Lahue, 1996) . Like p53, MSH2 interacts with recombination junctions with high affinity (Alani et al., 1997; Dudenho¨ffer et al., 1998; Marsischky et al., 1999; Su¨sse et al., 2000) . In further analogy to p53, the MSH2/MSH6 mismatch repair complex functions in the signaling pathways of the G2/M checkpoint and towards programmed cell death in response to some chemical carcinogens (Yamada et al., 1997; Durant et al., 1999; Fishel, 1999) .
BRCA1 represents another tumor suppressor, which like p53 and MSH2 performs regulatory activities during recombination, cell cycle progression, and the induction of apoptosis (Venkitaraman, 1999) . A role in recombination was anticipated from the observation of associations with Rad51 and with Rad50-Mre11-p95 complexes after irradiation (Scully et al., 1997a; Zhong et al., 1999) . More directly, it was recently demonstrated that BRCA1 directs double-strand break (DSB) repair from nonhomologous end-joining (NHEJ) into the nonmutagenic pathway of HR (Moynahan et al., 1999) . Rad50-Mre11-p95 complexes promote DSB repair via both NHEJ and HR pathways (Haber, 1998) . Rad51, in eukaryotes, plays the central role in the DNA-strand exchange processes of conservative HR pathways (Baumann and West, 1998) .
In our earlier studies (Dudenho¨ffer et al., 1998 (Dudenho¨ffer et al., , 1999 Su¨sse et al., 2000) , we have provided evidence for an involvement of p53 in recombination immediately following Rad51-mediated strand transfer. This is reminiscent of the proposed mechanism, by which MSH2 abrogates Rad51-mediated strand exchange upon encountering a mismatch (Alani et al., 1997) . To gain further insight into the relationship between p53 and MSH2 in recombination processes of mitotically growing cells, we analysed the spatial distribution of p53 and MSH2 with respect to BRCA1, Rad51, and Rad50 after irradiation and during the G1 to S phase transition. In addition, we studied possible interactions between p53 and MSH2 and compared the binding to DNA recombination intermediates under these cellular conditions.
Results

Analysis of p53 and MSH2 after g-ray treatment of mitotically growing cells
To compare the activities of p53 and MSH2 in the regulation of recombinative repair processes (Modrich and Lahue, 1996; Dudenho¨ffer et al., 1998) , we analysed the proteins after the introduction of DNA strand breaks by ionizing irradiation. Western blotting and PhosphorImager evaluation with total lysates from exponentially growing CV1 monkey cells demonstrated that the amount of wild-type p53 rose up to fivefold within 1 h in response to irradiation at doses up to 12 Gy, whereas MSH2 levels increased less than twofold ( Figure 1a ). For comparison, Rad51 accumulated 15-fold, and Rad50 less than twofold. Given that binding of recombination intermediates seems to be a central step for p53 and MSH2, to prevent HR between diverged sequences (Alani et al., 1997; Dudenho¨ffer et al., 1998 Dudenho¨ffer et al., , 1999 Su¨sse et al., 2000) , we performed gel shift analyses with nuclear extracts from CV1 cells and branched three-stranded (3s) DNAs, mimicking early recombination intermediates (Whitby and Lloyd, 1995; Dudenho¨ffer et al., 1998; see Figure 1b) . Specificity for these artificial recombination intermediates was ascertained by competition analyses, which demonstrated that at least a 1000-fold molar excess of tRNA or of poly dI/dC were required to compete for binding, and by controls with dsDNA and ssDNA ( Figure 6 ) of the same sequence content. The participation of p53 from irradiated cells in complexes with 3s DNA substrates was demonstrated by p53-specific antibodies. Thus, the retardation of the major DNA-protein complex band ( Figure 1b , lanes 1,5) was observed with the mAb DO1 (lane 2). Supershifting with PAb1620 verified that p53 from CV1 cells binds 3s DNA in its wild-type conformation (lane 3). Junction DNA interactions by p53 were enhanced in the presence of these antibodies, which is similar to the antibody-mediated activation of the cryptic sequencespecific DNA binding activity (Hupp and Lane, 1994) . PAb421, directed to the regulatory C-terminal end of p53 had almost no effect (lane 4), which probably reflects the inaccessibility of the respective epitope by posttranslational modifications (Hupp and Lane, 1994) . After the introduction of DNA damage DNAp53-antibody complex formation was enhanced twofold, as was quantified by phosphorimaging of the shifts and by normalizing the resulting values (n=3) with the p53 amounts in the nuclear fractions ( Figure  1b , lanes 11 versus 9). Bands supershifted with anti-MSH2 antibodies appeared similarly intense in cells treated with or without irradiation (Figure 1b, lanes 16  versus 14) .
To investigate the DNA damage-dependent nuclear localization pattern of the tumor suppressors involved in recombinative repair and cell cycle regulation, immunofluorescently labeled cells were inspected by confocal microscopy. With respect to p53 we detected a heterogenous population of nuclei ranging from finely distributed p53 to punctate staining for cells with or without g-ray treatment. Similar variations were observed with respect to MSH2. BRCA1 was observed in only a fraction of Log-phase cells, so that statistically significant correlations between the relative distribution of the three tumor suppressors were difficult to draw under these conditions. 5 CV1 cells, which had been treated with g-ray at doses of 5 or 12 Gy, were analysed by immunoblotting for the presence of p53, MSH2, Rad51, Rad50, and actin. The positions of M r marker bands are indicated for p53 and MSH2. The M r was calculated for Rad51, Rad50, and actin, as indicated. p53 from cells irradiated with 12 Gy appeared as an intense band at approximately 56 kD and additional faint bands resulting from proteolytic degradation and multiple posttranslational modifications (Abraham et al., 2000) . MSH2 from total cellular homogenates appeared as the full-length protein of 105 kD and as a truncated version of 90 kD (D), which was absent in nuclear extracts supplemented with protease inhibitors. (b) Gel mobility shift assays were performed with 32 P-labeled 3s recombination intermediates in the presence of a 10-fold molar excess of competitor tRNA and an aliquot of nuclear fraction n2. Log phase CV1 cells were either untreated or irradiated with 1.5 Gy (lanes 1 -5) or with 5 Gy (lanes 10, 11, 15, 16) , and harvested 1 h later. The positions of the DNA substrate and of the supershifted antibody-protein-DNA complexes are indicated by arrows. p53 within tetramers and MSH2 within heterodimers are known to bind to junction DNAs and are correspondingly drawn as components of these antibody-protein-complexes next to the left and to the right arrow, respectively. In lanes 1 -5, supershift assays were performed with the p53-specific antibodies DO1, PAb1620, and PAb421. In lanes 8 -11, p53-specific binding (DO1) and in lanes [13] [14] [15] [16] to 3s DNAs were compared for nuclear extracts from untreated cells and from cells exposed to 5 Gy. Where indicated, the control antibodies anti-E6 or anti-hER were included p53 and MSH2 at sites of recombination D Zink et al
G1 phase pattern of nuclear p53 and MSH2
To test whether heterogeneities seen in the nuclear distribution of p53 and MSH2 in mitotically growing cells were influenced by parameters related to the cell cycle stage of the individual cell, we explored the spatial relationship in synchronized CV1 cells. Isoleucine starvation and synchronous release for 2 h was performed to prepare G1-enriched cell populations (Figure 2b ). In these cultures [ 3 H]thymidine incorporation was measured to be less than 5% that of S phase cells, Cyclin A expression was not yet detectable in Western blots, and was confirmed for Cyclin E (Figure  2a,c) . In order to investigate the nuclear distribution pattern of p53, MSH2, and BRCA1, each protein was immunolabeled with a different fluorochrome, and these were imaged simultaneously by three-color confocal imaging. MSH2 was not uniformly distributed but revealed a focal pattern. A fraction of these MSH2 foci colocalized with prominent distinct focal enrichments of p53. It should be noted that in addition to the focal enrichments, a fraction of both proteins displayed also a more uniform distribution, in particular with regard to p53. This colocalization pattern was not altered when cells were irradiated 1 h before fixation (Figure 3a Foci formation of p53, MSH2, and BRCA1 during S phase A number of observations from virological, cell biological, and biochemical studies indicate links between p53 and DNA replication or replicationassociated repair processes (Huang, 1998; Ku¨hn et al., 1999 , and references therein). Consequently, we applied three-color confocal imaging on CV1 cells in S phase, to analyse the nuclear distribution of p53 relative to MSH2 and BRCA1 (Figures 4 and 5) . During the release of synchronized CV1 cells for 2 -15 h from isoleucin starvation, we monitored the exit from the G1 phase by [
3 H]thymidine incorporation, FACS analysis, and Cyclin A expression . p53 steady state levels in CV1 cells were rising approximately twofold from G1 to S phase, whereas MSH2 protein amounts stayed constant ( Figure 2c ). In cells, which predominantly were in S phase 15 h after release, p53 displayed an increased number of distinct focal enrichments as compared to G1 nuclei (Figures 3 Figure 2 Features of cells synchronized in G1 to S phase. (a) Logarithmically growing CV1 cells were starved in isoleucine-deficient medium and transferred to complete medium for synchronous release into S phase. At various times after transfer (release time), cells were labeled with 3 H-thymidine for 1 h and the incorporation of radioactivity into genomic DNA determined. The rate of DNA synthesis of exponentially growing cells was taken as 100%. (b) During the release the cell cycle distribution was followed flow cytometrically for propidium iodide stained cells. The release time is given at the x-axis, the y-axis show the percentage of cells in one cell cycle stage, which was quantified by marker regions in the histogram, as shown for asynchronously growing cells. Rhombic symbols indicate values of G1, squares of S, and triangles of G2 phase cell populations. (c) Expression levels of the cyclin E and cyclin A marker proteins for G1 and S phase were analysed in comparison to the amount of proteins involved in recombination. Western blots were performed with total homogenates derived from cells after different release times. For each time point half of the cells received a 5 Gy treatment 1 h before the harvest p53 and MSH2 at sites of recombination D Zink et al and 4). Independent of the treatment with g-ray, the majority of these p53 foci was found to coincide with MSH2 foci in the nuclei, as demonstrated by the corresponding composite stains (Figure 4c,g ). Vice versa, almost all MSH2 foci colocalized with the p53 foci (see statistics in Figure 9c ). When we visualized only discrete foci and removed the more uniformly distributed protein fraction by introducing a fluorescence intensity thresholding procedure (see Materials and methods), the resulting composite images emphasized the preferential colocalization of p53 and MSH2 within these structures (Figure 4d ,h). Using Balb/c 3T3 cells synchronized in S phase, we similarly observed colocalization of p53 and MSH2 within discrete foci (data not shown). In agreement with earlier studies (Vaughn et al., 1996; Scully et al., 1997a,b) , BRCA1 staining revealed a pattern of nuclear dots with increasing signal intensities at the G1/S transition (5 h, 7.5 h, 15 h after release). In irradiated S phase cells we observed a p53-and MSH2-like focal pattern for BRCA1. The composite stains for BRCA1 demonstrated a partial overlap with larger p53 foci 7.5 h and 15 h after release, i.e. in S phase ( Figure 5 ). Thus, the results demonstrate a colocalization of p53 and MSH2 within distinct focal structures in G1 and S phase cells. In contrast, BRCA1 localizes to these focal structures only in S phase cells after DNA damage.
Nuclear p53 and MSH2 are highly competent for junction DNA binding during S phase and are coimmunoprecipitated from crosslinked chromatin Given that p53 colocalizes with MSH2 and BRCA1 in nuclear foci of cells synchronized in S phase, we examined the DNA interactions of p53 after enrichment in nuclear extracts. Applying 3s recombination intermediates and the p53-specific antibody DO1, we noticed supershifted complexes with these extracts from S phase nuclei ( Figure 6a ). Thus, DO1-p53-DNA complexes appeared as the retarded band in Figure  6a , lane 8, of the major protein-DNA band in lane 7.
To compare the p53-dependent DNA-binding activities in asynchronously growing cells and in S phase cells, we performed quantitative shift analysis in parallel (n=3). The data were evaluated by phosphorimaging and normalized with the p53 amount in the respective nuclear fraction. In S phase cells we noticed a twofold enhancement, but DNA interactions were not further Figure 3 Immunofluorescence analysis of p53, MSH2, and BRCA1 in irradiated G1-phase cells. CV1 cells were synchronized in the cell cycle stage G1, treated with g-ray at a dose of 5 Gy, and fixed 1 h later. Three-color immunolabeling was followed by confocal imaging of nuclei. Mid-nuclear planes of one nucleus are shown: (a) p53, (b) MSH2, and (c) BRCA1 were detected with specific primary antibodies and subsequently with Cy3-conjugated anti-sheep IgG (p53), FITC-conjugated anti-rabbit IgG (MSH2), and Cy5-conjugated anti-mouse IgG (BRCA1), respectively. The overlay images were generated by superimposing pseudocoloured images of: (d) p53 (red, a) and MSH2 (green, b), (e) p53 (red, a) and BRCA1 (green, c), and (f) MSH2 (red, b) and BRCA1 (green, c). Yellow color represents colocalization. Some colocalizing foci containing p53 and MSH2 are indicated by arrowheads. Note the absence of colocalization in e and f. The green staining outside the nuclear area is due to some background staining in the cytoplasm regarding MSH2 With MSH2-specific antibodies we observed strong retardation of 3s DNA complexes, which was Figure 4 Nuclear foci of p53 and MSH2 during S phase. CV1 cells were synchronized in S phase and double-stained for: (a) and (e), p53 (red), and for: (b) and (f), MSH2 (green), as described in Figure 3 . (a) and (b) depict the identical nuclear plane of a nucleus without genotoxic treatment, whereas (e) and (f) show an identical plane of a nucleus, which had been irradiated at a dose of 5 Gy 1 h before fixation. For the visualization of colocalizing p53 and MSH2 foci (yellow) we generated overlay images from the original images ((c) for the images in (a) and (b), (g) for (e) and (f)). For (d) and (h) we introduced a threshold (see Materials and methods), to select for intensely fluorescing nuclear structures versus diffuse staining within the original images, and performed the same overlays as in (c) and (g) with the resulting images To allow the quantitative evaluation of the 3s DNA binding activities, reduced protein amounts were applied, so that an anti-MSH2 antibody dependent enhancement became apparent with S phase extracts, too. Under these conditions a twofold intensification of supershifted bands was measured in S phase versus Log phase cell extracts (n=2). These observations indicated that both p53 and MSH2 were highly competent for specific binding to nascent heteroduplex joints in S phase nuclei.
To test the existence of protein complexes containing p53 and MSH2, we analysed immunoprecipitates from asynchronously growing cells and from cell populations synchronized in G1 or S phase. For immunoprecipitations we used the mAbs DO1 and PAb421, directed towards the p53 N-and C-terminus, respectively, or the rabbit serum N-20, directed towards the Nterminus of MSH2. However, we were unable to detect MSH2 signals in p53 precipitates or p53 signals in MSH2 precipitates either from total cellular lysates or from nuclear extracts (data not shown). This observation suggested that direct physical interactions between p53 and MSH2 were not underlying the colocalization in nuclear foci. Reasoning that for both p53 and MSH2, protein-DNA interactions seem to be central steps during the surveillance of HR (Alani et al., 1997; Dudenho¨ffer et al., 1998 Dudenho¨ffer et al., , 1999 Su¨sse et al., 2000) , we asked whether immunocytochemical colocalization within foci reflected the independent, but concomitant association of p53 and MSH2 with large DNA repair complexes. Therefore, we assayed for indirect interactions between p53 and MSH2 using the techniques of immunoprecipitation analysis from in vivo crosslinked chromatin (Orlando and Paro, 1993) and in situ fractionation of nuclei (Schirmbeck and Deppert, 1989) . Since p53 and MSH2 from S phase nuclei displayed colocalization within numerous foci ( Figure  4) , we utilized correspondingly synchronized CV1 cells for the immunoprecipitation analyses. Indeed, now after chromatin crosslinking we detected p53 in anti-MSH2 immunoprecipitates, but not in control anti-TAg immunoprecipitates (Figure 7) . Reciprocally, in anti-p53 precipitates we also weakly saw MSH2 as the full-length and the proteolytically truncated variant. The coprecipitating bands comigrated with bands precipitated from the same extract with MSH2-specific antibodies. No such bands were precipitated with anti-T-Ag. Thus, our immunoprecipitation data provided further evidence for physical associations of p53 and MSH2 with the same DNA-protein complexes in the nuclei of replicating cells.
Presence of p53 and MSH2 in foci of recombination proteins during S phase Consistent with a role in HR, which utilizes two gene copies, Rad51 protein expression reaches a peak during S-phase in CV1 cells (Figure 2c) , as was previously shown for other cell types (Flygare et al., 1996) . AntiRad51 immunostaining, confocal imaging, and quantitative evaluation confirmed the expression profile of Rad51 from Western blots. Eighty-four per cent of both untreated (n=134) and of g-ray treated (n=129) G1 phase cells were devoid of any specific staining for Rad51, 9 -10% displayed a few Rad51 foci, and only 6 -7% showed numerous foci and diffuse nuclear staining. To the contrary, Rad51 staining was intense in all S phase cells, and displayed a punctate pattern with an additional diffuse component (Figure 8b) . Within 1 h after irradiation the number of Rad51 foci rose further and diffuse staining diminished (Figures 8e  and 9a) .
Since p53 and MSH2 play a role in regulating HR processes, we examined whether Rad51 was found at the same loci as these two tumor suppressors during S phase. We used two-color immunofluorescence and confocal imaging to investigate the relative distribution of p53 versus Rad51 and MSH2 versus Rad51 in CV1 S phase cells. To obtain statistically significant data, we firstly evaluated the p53 and MSH2 colocalization pattern quantitatively. For that purpose we scanned 10 two-color stained nuclei and subjected the fluorescence images to computer assisted evaluation using Metamorph software. This evaluation revealed that 70 -80% of the p53 foci colocalized with nuclear MSH2 foci in S phase cells, and around 90% of MSH2 foci Figure 7 Coimmunoprecipitation of p53 and MSH2 after in vivo crosslinking of chromatin. CV1 cultures were synchronized in S phase, subjected to formaldehyde in vivo crosslinking, and the nuclei fractionated in situ, as described in Materials and methods. Sonicated extracts were used for immunoprecipitations with the PGS-crosslinked antibodies PAb419 (anti-T-Ag), DO1 plus PAb421 (anti-p53), and N-20 (anti-MSH2). Immunoprecipitated proteins from 3610 5 CV1 cells each were applied to SDS gel electrophoresis next to total cellular homogenates (cell extract) from 1610 5 CV1 cells. For p53 with a molecular mass similar to the IgG heavy chain, we included controls of PGS-crosslinked antibodies without extracts (w/o extract). For immunoblotting against MSH2 we used N-20 from rabbit. p53 was detected with specific serum from sheep for precipitates with mouse mAbs (anti-T-Ag, anti-p53, anti-p53 w/o extract, cell extract) and with the murine antibody DO1 for precipitates with rabbit antibodies (anti-MSH2, anti-MSH2 w/o extract). Arrows signal the migration position of the full-length proteins p53 and MSH2 at sites of recombination D Zink et al with p53. This overlap was equally observed when cells had received 5 Gy (Figure 9c ). In agreement with the expression profile of p53 (Figure 2c ), we noticed an increase of p53 foci numbers after g-irradiation ( Figure  9a ). For the colocalization pattern with Rad51, we evaluated the confocal scans from 7 -10 representative nuclei for each combination correspondingly. Indeed, we observed a substantial number of the Rad51 foci to colocalize with p53 (Figures 8c and 9 ) and with MSH2 (not shown). Since 80% of all the p53 and 90% of all the MSH2 foci were found at positions of Rad51 foci (note in Figure 9a that there is a substantially higher number of Rad51 foci compared to p53 foci), whereas only 30% of the total nuclear area stained positive for Rad51, the overlapping localization of p53 or MSH2 and Rad51 does not reflect a random colocalization. Figure 8 Relative distribution of p53 with respect to foci of mammalian recombination proteins. Double-stained images of nuclei from CV1 cells in S phase were generated to compare the localization of: (a) and (d), p53 (red), with: (b) and (e), Rad51 (green), within corresponding mid-nuclear planes of two different nuclei. For (a) and (b) the cells were left untreated, for (d) and (e) cells were fixed 1 h after a treatment with 5 Gy. In (g), (h), (j), and (k) p53 (red) and Rad50 (green) were analysed correspondingly. Overlays in (c), (f), (i), and (l) were generated after fluorescence intensity thresholding of the two images displayed in the same line. Sites of colocalization appear yellow. Note colocalization in foci of high fluorescence intensity remaining after thresholding. Some of these colocalizing foci are indicated by arrows. The bar represents 5 mm p53 and MSH2 at sites of recombination D Zink et al
Irradiation did not significantly change the fraction of Rad51 foci overlapping with p53 (Figures 8f and 9 ). Rad50 protein is involved in both NHEJ and in the initiation of HR processes (Haber, 1998) . Consistently, Rad50 from CV1 cells was expressed in both G1 and S phase (Figure 2c ). Rad50 staining was characterized by small foci in addition to a prominent diffuse component, and did not display the large and discrete dots, which were seen for Rad51 during S-phase (Figure 8h,k versus b,e) . Irradiation-induced changes in Rad50 foci number were less than twofold. Since the evaluation of colocalizing foci was rendered more difficult, the introduction of a fluorescence intensity threshold to select for foci-like structures was required. After this procedure we noticed overlapping localization for most of the distinct Rad50 foci with p53 foci (Figures 8i and 9d ) and with MSH2 foci (not shown). This colocalization pattern was similar after the introduction of DNA damage (Figures 8l and 9d) . Taken together, the staining patterns from S phase cells showed a substantial colocalization of p53 and MSH2 foci with other nuclear proteins involved in recombinative DNA repair.
Discussion
p53 and MSH2 colocalize within nuclear foci
In this study, we provide the first immunocytochemical evidence for a common nuclear subcompartmentalization of the tumor suppressor proteins p53 and MSH2. In view of the checkpoint and repair-related functions of the two proteins, we utilized cells which were synchronized at distinct cell cycle stages and treated by ionizing radiation. We demonstrate that during G1 phase, but particularly during S phase, p53 is partitioned within focal enrichments in addition to a more uniform distribution throughout the nucleus. MSH2 foci displayed a striking colocalization with p53 foci particularly in S phase, suggesting an involvement in the same biological processes at these loci. Nevertheless, we also noticed some p53 foci at separate loci, especially in G1 phase. These differences in the nuclear partitioning might reflect unique properties of p53, such as transcriptional transactivation of specific target genes. In G1 phase p53 is known to play a major role as a checkpoint factor via transcriptional transactivation, whereas in cells chemically synchronized in S phase, p53 is transcriptionally inactive (Lane, 1992; Levine, 1997; Gottifredi et al., 2001) . Conversely, during DNA replication an increasing involvement in HR processes was predicted for p53 from the increasing availability of homologous sister chromatids. Indeed, most recently, Saintigny and Lopez (2002) demonstrated p53-dependent regulation of HR, which was stimulated by replication inhibitors.
Association with recombinative repair complexes
Rad51 levels rise at the beginning of S phase and cause the recruitment of Rad51 into nuclear foci (Flygare et al., 1996; Tashiro et al., 1996; Scully et al., 1997a ). As we demonstrate here, g-irradiation during S phase further enhances the formation of Rad51 foci even within one hour after treatment. These complexes are expected to represent functional recombinational repair complexes, because Rad51, replication protein A (RPA), and Mre11 localize to ssDNA or DNA breaks within 15 -60 min after irradiation (Nelms et al., 1998; Raderschall et al., 1999; Tashiro et al., 2000) . Indicating a fast response also with respect to factors, which play a regulatory role in recombination repair pathways, DNA damage-associated phosphorylation of BRCA1 takes place within 30 -60 min (Scully et al., 1997b) . Here, we found p53 to be increasingly concentrated within nuclear foci of S phase cells 60 min after irradiation. These foci not only displayed Figure 9 Quantitative evaluation of the colocalization patterns for Rad51, Rad50, MSH2, and p53 foci. (a) Discrete nuclear foci of p53 (red) and Rad51 (green) were identified according to the thresholding procedure from double-stained confocal images explained in Materials and methods. Ten nuclei from untreated (0 Gy) or from g-irradiated (5 Gy) S phase cells were evaluated for colocalization of p53 foci with Rad51 foci or for Rad51 foci with p53 foci by counting and summarizing (total) the numbers of yellow colocalizing versus red or green free foci. Mean values were calculated. (b) Mean values for the relative fraction of colocalizing (Rad51 & p53) versus free Rad51 foci derived from the data in (a) are shown graphically. For the colocalization analyses of (c), MSH2 foci with p53 foci, and (d) Rad50 foci with p53 foci, the data from 7 -10 double-stained nuclei were obtained correspondingly p53 and MSH2 at sites of recombination D Zink et al a significant colocalization within MSH2, but also with the strand transferase Rad51. Interestingly, from G1 to S phase, we also observed the dynamic association of p53 foci with the HR promoting factor BRCA1 (Moynahan et al., 1999) . This suggested that in cells undergoing DNA replication p53 and MSH2 are found at sites of recombinative repair. Even further, this finding indicated that p53 performs genome stabilizing functions during S phase. Interestingly, in our experiments we noticed a major fraction of Rad51 dots at sites, which were not occupied by either p53 or MSH2. In the same cells, we observed at least a partial overlap for almost every distinct Rad50 focus with p53 staining, although more than half of the nuclear p53 foci were localized elsewhere due to the higher number of p53 foci compared to the few confined Rad50 foci. Mre11-Rad50 complexes are necessary for the initiation of HR, which represents the predominant DSB repair pathway in replicating cells, as opposed to NHEJ (Haber, 1998; Lambert et al., 1999; Flores-Rozas and Kolodner, 2000) . Rad51 is required for initial and continued strand exchange during HR (Baumann and West, 1998) . Thus, from these findings, from our previous biochemical studies (Dudenho¨ffer et al., 1998 (Dudenho¨ffer et al., , 1999 Su¨sse et al., 2000) , and from a recent report describing binding of early HR intermediates by MSH2 in a Rad50-dependent manner (Evans et al., 2000) , p53 and MSH2 are likely to monitor recombination during initial strand invasion rather than during branch migration.
Recognition of heteroduplex joints as a possible mechanism for the recruitment into S phase foci Nuclear MSH2 molecules displayed maximal competence for specific interactions with heteroduplex joints during S phase, p53 molecules during S phase or after irradiation. Therefore, modification or other cellular mechanisms seem to generate MSH2 and p53 proteins, which strongly recognize recombination intermediates. Thus, it is conceivable that the formation of S phase specific p53 and MSH2 foci are driven by specific DNA interactions. The interactions of recombinant p53 and MSH2 proteins with recombination intermediates have been characterized by high binding affinities (Gradia et al., 1997; Dudenho¨ffer et al., 1998; Marsischky et al., 1999) . They were reported to be 40 -100-fold higher as compared to the interactions with sequence-specific transcriptional response elements by p53 homotetramers and to the interactions with G-T mismatch duplex DNAs by MSH2/MSH6 heterodimers, respectively. This provides the basis for a specific and immediate response to the appearance of DNA exchange events despite the multifunctionality of both tumor suppressors. Our immunoprecipitation experiments without or with prior chromatin crosslinking unveiled associations of p53 and MSH2 with the same DNA-protein complexes without strong, direct physical interactions between the two tumor suppressors. These observations suggest that p53 and MSH2 are independently targeted to sites of replication-associated DNA repair by the recognition of related DNA structures, repair proteins, or both.
Possible roles of focal p53 and MSH2 enrichments in S phase cells
Rad51 and BRCA1 were shown to become recruited to replication centres after treatment with either hydroxyurea or UV in S phase (Scully et al., 1997a,b) . More directly, Saintigny et al. (2001) correlated Rad51 foci formation and Rad51-dependent gene conversion in response to replication inhibition. Therefore, Rad51 dots, described here for CV1 cells in S phase, most likely identify sites of recombinative repair, where replication forks encounter unrepaired lesions. It was also demonstrated that Rad50-Mre11-p95 and MSH2 associate with BRCA1 in a multi-component complex together with MSH6, MLH1, ATM, BLM, and replication factor C (Wang et al., 2000) . This complex again associates with replication centres after hydroxyurea treatment, so that a role in the surveillance of replication-associated repair was postulated. Interestingly, in our study we noticed dynamic changes of the BRCA1 localization pattern from G1 to S phase, starting from a p53-and MSH2-independent punctate pattern to the appearance of foci, which partially overlapped with p53 foci. This effect was most pronounced after girradiating the cells. These observations suggest that both p53 and MSH2 are recruited to BRCA1-associated surveillance complexes at sites of replication-associated repair. At these sites downregulation of HR by p53 might be caused by an abrogation of Rad51-mediated strand transfer, in analogy to the proposed role of MSH2 during exchange between divergent sequences (Modrich and Lahue, 1996) . Another possible meaning of the p53 colocalization with the recombination machinery during S phase is that p53 controls the correct alignment or the replicative extension of the 3' invading end, since p53 forms complexes with DNA polymerase a and b, excises mismatched nucleotides in a replication assay, and shows reduced exonucleolytic activities, when the distance is raised between the junction and the heteroduplex terminus (Huang, 1998; Ku¨hn et al., 1999; Zhou et al., 2001; Janz et al., 2002) . In agreement with the latter possibility, a role of p53 in creating a threshold for recombination between short versus long homologies was proposed from studies on the stability of repetitive sequences (Gebow et al., 2000) . In support of a complementary role of p53 and MSH2 in the fidelity control of DNA repair and/or replication, it was found that loss of p53 and MSH2 causes a synergistic increase in the rate of frameshift mutations in CA repair tracts after genotoxic treatment (Lin et al., 2000) .
Another possible meaning of the recruitment of p53 to recombination complexes, as indicated by our data, is the transmission or modulation of growth-regulatory signals. In support of a signaling role p53 and MSH2 at sites of recombination D Zink et al downstream of recombination, the concomitant knockout of p53 in mice nullizygous for Rad51 or BRCA1 partially suppresses the arrest of embryo development (Lim and Hasty, 1996; Hakem et al., 1997) . MSH2 plays a role in signaling to p53, and p53 in regulating the MSH2 gene, thereby generating a regulatory feedback loop (Duckett et al., 1999; Scherer et al., 2000) . Thus, the p53 and MSH2 foci described here may be important sites for the dual functions of these tumor suppressor proteins in regulating repair and growth.
Conclusions
From the data presented in this work, we propose the following explanation for the focal colocalization of p53 and MSH2: it has been shown that MSH2 and p53 recognize mispairings in dsDNA and in nascent heteroduplex joints, suggesting similar functions in either mismatch repair or in suppressing error-prone DNA exchange. Here, we demonstrate that p53 and MSH2 colocalize in focal enrichments particularly in S phase cells. This implies that both molecules assemble into a complex, which is likely to be involved in monitoring the integrity of the DNA. From the colocalization with BRCA1, Rad51, and Rad50 in S phase, important sites of surveillance could be sites of replication-associated repair.
Materials and methods
Cell culture, synchronization, cell cycle analysis, and irradiation CV1 (Cercopithecus aethiops) green monkey cells from passage 8 were raised, as described (Wiesmu¨ller et al., 1996) . For synchronization logarithmically growing cells were washed twice and transferred to isoleucine free DMEM supplemented with 5% dialysed FCS for 70 h. Cultures were then stimulated to start DNA synthesis by the addition of complete DMEM with 10% FCS. For the measurement of DNA synthesis cells were pulse labeled with [ 3 H]thymidine and the incorporated radioactivity was counted in TCA precipitates. For the analysis of cell cycle phases by flow cytometry 1 -5610 6 cells in Log phase or after 2 -15 h release from isoleucine starvation were collected by trypsinization and centrifugation, resuspended in 1 ml HBSS (25 mM HEPES, (pH 7.4); 173.3 mM NaCl; 5.6 mM KCl; 0.44 mM KH 2 PO 4 ; 0.34 mM Na 2 HPO 4 ; 5 mM glucose; 4 mM NaHCO 3 ), and fixed in 10 ml fixing solution (50% acetone; 40% ethanol; 10% ddH 2 0; at 7208C) on ice for 15 min. For subsequent staining, fixed cells were washed with 2.5 ml ice-cold PBS supplemented with 0.2% EDTA, resuspended in 100 ml propidium iodide staining solution (0.25 mg/ml RNAse A; 50 mg/ml propidium iodide from Sigma in PBS), and incubated for 15 min in the dark. After diluting the suspension by 200 ml PBS with 0.2% EDTA, the stained cells were analysed in a Coulter Counter EPICS XL-MCL TM flow cytometer. The quantitative evaluation of cells in various cell cycle phases was achieved by use of the SystemII TM software. For g-ray treatment of cells in culture we used a [
137 Cs] source. If not stated otherwise, the cells received a dose of 5 Gy and cultivation was continued for 1 h before harvest.
Antibodies
We used the following mouse mAbs: PAb421 directed against the C-terminal amino acids 372 -382 of p53 (Harlow et al., 1981b) , PAb1620 specific for the wild-type conformation and DO1 against amino acids 21 -25 of human p53 (Calbiochem), MS110 recognizing the N-terminal 304 amino acids from human BRCA1 (Calbiochem; Scully et al., 1997a,b) , Calbiochem antibody against cyclin A, anti-hER (C-311) against the estradiol binding domain of the human estrogen receptor (Santa Cruz), Ab-1 recognizing E6 from HPV16/18 (Oncogene Science), PAb419 against SV40 T-Ag (Harlow et al., 1981a) , antibodies against cyclin E (Pharmingen). For the detection of human Rad50 in Western blots we used mouse IgG1 recognizing the epitope 672-786 (Pharmingen), for human Rad51 goat polyclonal IgG (I-20) or rabbit polyclonal antibodies (H-92) raised against amino acids 1-92 (Santa Cruz), and for actin goat polyclonal IgG (I-19) (Santa Cruz). For immunofluorescence analyses of Rad50 and Rad51 we applied the same specific rabbit antisera, which have been described before (Dolganov et al., 1996; Tashiro et al., 1996) . The IgG fraction of sheep serum raised against human p53 (Roche Diagnostics) and affinity-purified polyclonal rabbit serum N-20 against amino acids 2 -21 of MSH2 (Santa Cruz; Wang et al., 2000) were used for both immunofluorescence and Western analyses, if not stated otherwise. The specificity of the anti-p53 IgGs was confirmed by immunoblots utilizing p53 positive and negative cells. Peroxidase-, FITC-, Cy3-, and Cy5-conjugated affinity purified antibodies against goat, sheep, rabbit, and mouse IgG were obtained from Dianova, Sigma, or Biomol.
Immunoblotting and immunoprecipitation
Homogenates of 2610 5 cells were harvested, electrophoresed on 8 -12% polyacrylamide gels, Western blotted, and subjected to quantitative evaluation, as described (Dudenho¨ffer et al., 1999) . For immunoprecipitations, we either used total cellular lysates or nuclear extracts, which were prepared as described for insect cells (Dudenho¨ffer et al., 1999) , according to the protocol from Dignam et al. (1983) , or by in situ fractionation of nuclei after chromatin crosslinking. Protease inhibitors (125 mg/ml pefabloc, 5 mg/ml pepstatin, 5 mg/ml leupeptin, and 5 mg/ml aprotinin) were included into all extraction buffers. For immunoprecipitations the extracts were adapted to pH 8, 300 mM NaCl, and 0.2% NP40. After preclearing the extracts with protein G-Sepharose (PGS from Pharmacia) for 1 h, 1 -3 mg of antibody coupled to 10 ml of PGS were added per 1610 6 cell equivalent. The mixture was incubated for 3 -16 h at 48C on a rotary shaker. PGScoupling was achieved by a treatment with 20 mM dimethyl pimelimidate (Sigma) in 0.2 M sodium borate buffer (pH 9) for 1 h, which was followed by quenching of the reaction with 0.2 M ethanolamine for 1 h. Immunoprecipitated proteins were washed five times with 50 mM HEPES (pH 7.5), 150 mM NaCl, 0.1% NP40, boiled for 10 min in SDS sample buffer (Dudenho¨ffer et al., 1999) , and separated by SDS -PAGE in 10% polyacrylamide gels. Protein concentrations were determined according to the BCA protein assay (Pierce GmbH). Protein amounts were quantified after scanning the autoradiographies by computer-assisted analysis using the Tina 2.0 software.
Chromatin crosslinking and in situ fractionation of nuclei
Chemical crosslinking of 3610 6 cells on three 90-mm plates was performed by adding formaldehyde directly to the p53 and MSH2 at sites of recombination D Zink et al growth medium to reach a final concentration of 1% and by incubating the culture plates at room temperature for 10 min (Orlando and Paro, 1993) . Cells attached to the tissue culture plates were transferred on ice, washed twice with ice-cold PBS, and extracted in situ by using the published procedure without DNase I treatment (Schirmbeck and Deppert, 1989 ). The nuclear structures, which had remained attached to the substratum after extraction, were resuspended in 10 mM Tris (pH 8.0), 1 mM EDTA, and protease inhibitors, To shear the crosslinked chromatin into approximately 1 kb DNA fragments, we sonified these suspensions 6615 s with the microtip of the Branson model 250 at power setting 5. The extract was cleared by centrifugation at 10 000 g and subjected to immunoprecipitation.
Preparation of nuclear extracts and gel mobility shift assays
A total of 3610 7 cells were collected from thirty 90-mm plates, rinsed twice with ice-cold PBS, and extracted, as described (Dudenho¨ffer et al., 1998) . After dounce-homogenization, incubation, and centrifugal separation of nuclei in 1.5 ml of 10 mM HEPES (pH 7.4), 1.5 mM MgCl 2 , 5 mM KCl, 1 mM DTT, cytosolic and nucleosolic proteins remained in the supernatant. Nuclear fraction n1 was obtained by extracting the isolated nuclei at pH 9.0. Further extraction steps with 200 mM KCl and subsequently with 500 mM KCl resulted in nuclear fractions n2 and n3. n2-extracts from asynchronously growing and from S phase cells were strongly enriched in p53 and MSH2, and therefore chosen for DNA binding analyses. Prior to each series of band shifts, we normalized the n2-extracts with respect to the total protein concentrations, and determined the appropriate volume by titration analysis. Thus, to obtain at least weak DNA complex formation with extracts from asynchronously growing cells, n2-aliquots with total protein amounts of 400 -700 ng were employed. ssDNAs and 3s junction DNAs were prepared and gel shifted as described (Dudenho¨ffer et al., 1998) . Briefly, artificial 3s DNA substrates encompass random sequences within the SV40-VP1 gene and were prepared by simultaneously annealing the 66-mer 'top' (5'-end labeled) oligo, the 66-mer 'A-G central' oligo, and the 64-mer 'bottom' oligo. Thereby, a flexible 3s junction of 15 bp was created in the centre of the hybrid as well as an A -G mismatch 16 bp distant from the terminus of the heteroduplex between the oligonucleotides 'top' and 'A-G central'.
32 P-labeled junction DNA was isolated by native electrophoresis in a TBEbuffered 6% polyacrylamide gel. Labeled and purified ssDNAs ('top' oligo) or 3s DNAs were added to the standard DNA binding mixtures at a constant concentration of 50 pM together with competitor tRNA (ICN) at 500 pM, incubated on ice for 30 min, and electrophoresed on a native 4% polyacrylamide gel. For supershifting 100 -200 ng of specific antibodies were applied, and substituted by the corresponding amount of BSA, anti-E6, or anti-hER antibody in the remaining mixtures. Dried gels were autoradiographed and band intensities quantified by Phosphorimager analysis.
Immunofluorescence microscopy
Cells were seeded at a density of 2 -3610 5 per 76626 mm glass slide, raised overnight, synchronized, and/or irradiated. The slides were fixed with 3.7% formaldehyde in PBS for 10 min. Fixed slides were saturated and permeabilized with BSA buffer (0.3% triton, 0.3% tween, 5% BSA in PBS), and incubated with the primary and secondary FITC-, Cy3-, or Cy5-conjugated antibody in the same buffer for 1 h at room temperature. PBS was used for the washing steps in between (565 min each). Antibodies were used at dilutions of 1/50 -1/200. Following DAPI counterstaining with 0.1 mg/ml in PBS for 5 min, the preparations were mounted in Vectashield (Linaris, Wertheim). Optical sectioning was carried out with a Leica TCS 4D confocal microscope as described in Eils et al. (1996) . To control for bleed through of FITC fluorescence through Cy3-detection filters, we used the 488 nm laser line for FITC excitation in combination with the filters used for Cy3 detection. Vice versa, to control for bleed through of Cy3-fluorescence through the FITC detection filters, we excited with the 568 nm laser line and detected with the filter set used for FITC detection. Images collected in the Zseries were viewed, quantitatively evaluated, and arranged by the Metamorph software (version 3.6; Universal Imaging Corp.). For automated image analysis, especially for overlay procedures, images had to be thresholded. The threshold was set that the fraction of uniformly distributed protein was excluded and only local protein enrichments stained with high fluorescence intensity were included. Among these brighter foci, only those which had a diameter of 400 nm or more were counted automatically by the measure tool of Metamorph. A threshold, once established, was retained at least for all images concerning one specific protein combination. For colocalization analysis, thresholded images were overlaid, and colocalizing foci, appearing in a different colour (signal53006300 nm) were counted. For double-staining studies with rabbit sera against MSH2 and Rad51 or against MSH2 and Rad50 the preparations were incubated first with the primary antibody for MSH2, followed by an incubation with a 1/50 dilution of the Cy3-conjugated anti-rabbit serum overnight to saturate antigenic sites. After washing, the slides were fixed with formaldehyde and staining was continued for Rad51 or Rad50 with the corresponding primary antibody and the FITC-coupled secondary antibody. For these and other two-and three-colour stainings we assured the absence of signals from crossreactivities of the secondary antibodies by performing controls with only one primary antibody and both secondary antibodies.
